Trajectories of Motor Development

References

• Mayes L C, Granger R H, Bornstein M H, Zuckerman B. The problem of prenatal cocaine exposure: a rush to judgement. JAMA. 1992; 267: 406–408
   PubMed Web of Science ®Google Scholar
• Lester B M, Tronick E Z. The effects of prenatal cocaine exposure and child outcome. Inf Mental Health J. 1994; 15: 107–120
   Google Scholar
• Schneider J W, Chassnoff I J. Motor assessment of cocaine-exposed infants. PediatrRes. 1987; 21: 184
   Google Scholar
• Schneider J W, Chasnoff I J. Motor assessment of cocaine/polydrug exposed infants at age 4 months. Neurotoxicol Teratol. 1992; 14: 97–101
   PubMed Web of Science ®Google Scholar
• Coles C D, Platzman K A, Smith I, et al. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxicol Teratol. 1992; 14: 23–33
   PubMed Web of Science ®Google Scholar
• Beeghly M, Tronick E Z. Effects of prenatal exposure to cocaine in early infancy: toxic effects on the process of mutual regulation. Inf Mental Health J. 1994; 15: 158–175
   Web of Science ®Google Scholar
• Neuspiel D R, Hamel S C, Hochberg E, et al. Maternal cocaine use and infant behavior. Neurotoxicol Teratol. 1991; 13: 229–233
   PubMed Web of Science ®Google Scholar
• Chasnoff I J, Burns W J, Schnoll S H, et al. Effects of cocaine on pregnancy outcome. National Institute of Drug Abuse Research Monograph Series. 1986; 7: 335–341
   Google Scholar
• Chasnoff I J, Griffith D R, Freier C, et al. Cocaine/polydrug use in pregnancy: two year follow-up. Pediatrics. 1992; 89: 284–289
   PubMed Web of Science ®Google Scholar
• Schneider J W, Lee W, Chasnoff I J. Field testing of the Movement Assessment of Infants. Phys Then 1988; 68: 321–327
   PubMed Web of Science ®Google Scholar
• Hurt H H, Brodsky N L, Betancourt L, et al. Cocaine exposed children: follow-up through 30 months. Dev Behav Pediatr. 1995; 16: 29–35
   PubMed Web of Science ®Google Scholar
• Fetters L, Tronick E Z. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance. Pediatrics. 1996; 98: 938–943
   PubMed Web of Science ®Google Scholar
• Ostrea E M, Brady M J, Parks D C. Drug screening of meconium in infants of drug dependent mothers: an alternative to urine testing. J Pediatr. 1989; 115: 474–477
   PubMed Web of Science ®Google Scholar
• Piper M, Darrah J. Infant Motor Scale. Saunders, Philadelphia, PA 1995
   Google Scholar
• Chandler L S, Andrews M S, Swanson M W. Movement Assessment of Infants: A Manual. Rolling Bay, WA 1980
   Google Scholar
• Folio M R, Fewell R R. Peabody Developmental Motor Scales and Activity Cards Manual. DLM Teaching Resources, Allen, TX 1983
   Google Scholar
• Frank D A, Bresnahan K, Zuckerman B S. Maternal cocaine use: impact on child health and development. Mosby-Year Book, Inc., Adv Pediatr 1993; 65–99
   Google Scholar
• Chasnoff I J, Griffith D R, MacGregor S, et al. Temporary patterns of cocaine use in pregnancy: perinatal outcome. JAMA. 1989; 261: 1741–1744
   PubMed Web of Science ®Google Scholar
• Zuckerman B, Frank D, Hingson R, et al. Effects of maternal marijauna and cocaine use on fetal growth. NewEnglJ Med. 1989; 320: 762–768
   PubMed Web of Science ®Google Scholar
• Thelen E. Determinants of amounts of stereotyped behavior in normal human infants. Ethology and Sociobiology. 1980; 1: 141–150
   Web of Science ®Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences2nd ed. Erlbaum, Hillsdale, NJ 1988
   Google Scholar
• Rosenthal R, Rosnow R L. Essentials of Behavioral Research: Methods and Data Analysis2nd ed. McGraw-Hill, New York, NY 1991
   Google Scholar
• Holt K G. Constraints in the emergence of preferred locomotory patterns. Timing of Behavior: Neural, Computational, and Psychological Perspectives, D A Rosenbaum, C E Collyer. MIT Press. 1997
   Google Scholar
• Mayes L C. Neurobiology of prenatal cocaine exposure: effect on developing monoamine systems. Inf Mental Health J. 1994; 15: 121–133
   Google Scholar
• Chiriboga C A, Bateman D A, Brust J C M, et al. Neurologic findings in neonates with intrauterine cocaine exposure. Pediatr Nenrol. 1993; 9: 115–119
   Google Scholar
• Needleman R, Zuckerman B S, Anderson G, et al. CSF monomine precursors and metabolites in human neonates following in utero cocaine exposure. Pediatr Res. 1992; 31: 13A
   Google Scholar
• Spear L P, Kirstein L K, Frambes N A. Cocaine effects on the developing central nervous system: behavioral, psychopharmacological, and neurochemical studies. Ann New York Acad Sei. 1989; 562: 290–307
   PubMed Web of Science ®Google Scholar
• Tronick E Z, Beeghly M. Effects of prenatal exposure to cocaine on newborn behavior and development: a critical review. OSAP Monograph Series: Identifying the needs of drug-affected children: Public Policy Issues. 1992; 11: 25–48
   Google Scholar
• Lester B, Tronick E. Newborn Behavioral Assessment Scale and NNNS. Biobehavioral Assessment of the Newborn and Young Infant: Developmental Models and Implications for the Infant at Risk, P S Zeskind, L Singer. Guilford Publications, New York, NY, in press
   Google Scholar
• Dixon S D. Neurological consequences of prenatal stimulant drug exposure. Inf Mental Health J. 1994; 15: 134–145
   Google Scholar
• Mirochnick M, Meyer J, Frank D, Tronick E, Zuckerman B, Carbal H. Elevated plasma norepinehprine following in utero exposure to cocaine and marijuana. Pediatrics. 1997; 4: 555–559
   Google Scholar
• Volpe J J. Effects of cocaine use on the fetus. New Engl.1 Med. 1992; 327: 399–407
   PubMed Web of Science ®Google Scholar
• Tronick E Z, Frank D A, Cabral H, et al. Late dose response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics. 1996; 98: 76–83
   PubMed Web of Science ®Google Scholar
• Rose-Jacobs R, Fetters L. Quantitative assessment of the development of reaching in healthy preterm infants at 7, 9 and 12 months. Pediatric Physical Therapy. 1989; 1: 183
   Google Scholar